|
|
||||||||
The Journal of Immunology, Vol 153, Issue 10 4573-4582, Copyright © 1994 by American Association of Immunologists
ARTICLES |
T Takeda, K Nakajima, H Kojima and T Hirano
Division of Molecular Oncology, Osaka University Medical School, Japan.
Some viral products interfere with host antiviral defense mechanisms. Adenovirus E1A represses IFN signal transduction pathways which induces gene activation and an antiviral state. Both IFN and IL-6 activate Jak/Tyk protein tyrosine kinases and the STAT (signal transducer and activator of transcription) family proteins. We showed that 12S E1A repressed IL-6 signals activating the junB promoter and the two IL-6 response elements (REs), JRE-IL6 and type II IL-6 RE (also called acute phase response element), required for IL-6-induced activation of the junB promoter and the type II acute phase reactant genes, respectively, in hepatocytes. Conserved region 1 of the 12S E1A was responsible for the repression. Target molecules of the repression by E1A appeared to be IL-6-inducible DNA-binding proteins acting on the IL-6 REs. In a rat 3Y1 cell line stably expressing E1A, the levels of IL-6-induced IL-6 RE binding proteins were severely reduced compared with those in a parental 3Y1 cell line. Moreover, we found that the levels of the STAT family proteins including Stat1-alpha (p91), Stat1-beta (p84), Stat2 (p113), and Stat3 were decreased by the stable expression of adenovirus E1A. The E1A-induced reduction in the amount of DNA-binding proteins seemed to be partly responsible for the decreased transcriptional activity of the IL-6 RE-driven gene expression in response to IL-6. This repression mechanism may be applicable to the E1A repression of IFN-gamma-induced gene activation.
This article has been cited by other articles:
![]() |
R. Minekawa, M. Sakata, Y. Okamoto, M. Hayashi, A. Isobe, T. Takeda, T. Yamamoto, M. Koyama, M. Ohmichi, K. Tasaka, et al. Involvement of RelA-Associated Inhibitor in Regulation of Trophoblast Differentiation via Interaction with Transcriptional Factor Specificity Protein-1 Endocrinology, December 1, 2007; 148(12): 5803 - 5810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fukuda, M. Abematsu, H. Mori, M. Yanagisawa, T. Kagawa, K. Nakashima, A. Yoshimura, and T. Taga Potentiation of Astrogliogenesis by STAT3-Mediated Activation of Bone Morphogenetic Protein-Smad Signaling in Neural Stem Cells Mol. Cell. Biol., July 1, 2007; 27(13): 4931 - 4937. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lundquist, B. Barre, F. Bienvenu, J. Hermann, S. Avril, and O. Coqueret Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition Blood, May 15, 2003; 101(10): 4070 - 4077. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, C. McKerlie, S. H. Borenstein, Z. Lu, M. Schito, J. W. Chamberlain, and M. Buchwald Transgenic Expression in Mouse Lung Reveals Distinct Biological Roles for the Adenovirus Type 5 E1A 243- and 289-Amino-Acid Proteins J. Virol., July 29, 2002; 76(17): 8910 - 8919. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Terstegen, P. Gatsios, S. Ludwig, S. Pleschka, W. Jahnen-Dechent, P. C. Heinrich, and L. Graeve The Vesicular Stomatitis Virus Matrix Protein Inhibits Glycoprotein 130-Dependent STAT Activation J. Immunol., November 1, 2001; 167(9): 5209 - 5216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pauschinger, N. E. Bowles, F. J. Fuentes-Garcia, V. Pham, U. Kuhl, P. L. Schwimmbeck, H.-P. Schultheiss, and J. A. Towbin Detection of Adenoviral Genome in the Myocardium of Adult Patients With Idiopathic Left Ventricular Dysfunction Circulation, March 16, 1999; 99(10): 1348 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Juompan, P. Lambin, and M. Zouali Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection FASEB J, November 1, 1998; 12(14): 1473 - 1480. [Abstract] [Full Text] |
||||
![]() |
T. Takeda, H. Kurachi, T. Yamamoto, H. Homma, K. Adachi, K. Morishige, A. Miyake, and Y. Murata Alternative Signaling Mechanism of Leukemia Inhibitory Factor Responsiveness in a Differentiating Embryonal Carcinoma Cell Endocrinology, July 1, 1997; 138(7): 2689 - 2696. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |